🎁 Black Friday: up to 50% off of annual plans
Helixmith Co., Ltd (KOSDAQ:084990)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,175.00
-195.00 (-5.79%)
Nov 20, 2026, 3:30 PM KST

Helixmith Revenue

Helixmith had revenue of 448.18M KRW in the quarter ending September 30, 2026, a decrease of -20.63%. This brings the company's total for the last twelve months to 2.30B, down -38.43% year-over-year. In the year 2025, Helixmith had annual revenue of 2.60B, down -47.77%. That makes Helixmith the 42,707th largest company in the world by revenue and 2,578th in South Korea.

Revenue (ttm)
2.30B
Revenue Growth
-38.43%
P/S Ratio
63.47
Revenue / Employee
60.61M
Employees
38
Market Cap
146.20B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Pharmaceutical Research and Development Projects, Etc. 3.07B 100.0%

By Geography

Chart
  • South Korea 1.39B 53.4%
  • America 923.99M 35.6%
  • Asia 287.49M 11.1%
Fiscal year ended Dec 31, 2025 See the full Helixmith breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.60B-2.38B-47.77%
Dec 31, 20244.97B772.35M18.38%
Dec 31, 20234.20B1.40B50.08%
Dec 31, 20222.80B483.36M20.87%
Dec 31, 20212.32B-1.93B-45.48%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2013 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Bioneer345.88B
GC Cell162.00B
HLB Therapeutics64.45B
GC Genome32.64B
SillaJen10.77B
Anterogen.Co.,Ltd.9.29B
NeoImmuneTech6.60B
Genexine5.81B
Revenue Rankings